In California, Amyris, Inc. completed a previously announced joint venture agreement with MF 92 VENTURES LLC, a Minerva Foods subsidiary, to develop molecules for the sustainable production and distribution of animal protein. Minerva and Amyris will collaborate on the development, scale-up and production of new target molecules, which Minerva will fund and bring to market […]
It was as busy as a mosh pit, as coordinated and fluid as Astaire and Rogers — the penny dropped on what the Unites States of America plans to do about sustainable aviation fuels, with more than a dozen companies and government agencies in the mix, as US airlines agreed to reach 3 billion […]
In California, Amyris, Inc. achieved promising in-vivo results in a study of its licensed RNA vaccine through intranasal delivery, developed in collaboration with the Infectious Disease Research Institute (IDRI), which means an effective Covid-19 nose spray vaccine could become reality. In-vivo results indicate that, when delivered to the mucosal membranes via intranasal administration, the Amyris/IDRI […]
In California, Amyris, Inc. reports another record quarter of underlying revenue, another record quarter of consumer revenue and significant gross margin expansion, and a strong cash position and robust outlook into second half 2021. “With Q2 we completed another quarter of strong strategic and operational execution,” said John Melo, President and Chief Executive Officer. “We […]
In California, Amyris, Inc. signed an exclusive license with Nant Africa, LLC relating to the development and use of the RNA COVID vaccine Amyris developed in coordination with the Infectious Disease Research Institute (IDRI). Amyris’ partnership with Nant Africa is of significant value to Amyris as it provides the fastest path to market for the […]
In California, Amyris, Inc. has signed an agreement with Ingredion Incorporated for the exclusive licensing of Amyris’s zero-calorie, nature-based, fermented Reb M sweetener. In addition, the agreement includes an Ingredion minority ownership stake in the Amyris Brazilian manufacturing facility that is currently under construction. The transaction value is estimated to be $100 million. This includes […]
In California, synthetic biology and renewable chemicals maker Amyris has partnered with acting powerhouse Reese Witherspoon to promote clean beauty products. Witherspoon, whose credits include Legally Blonde and Little Big Lies, will be the global brand ambassador for Amyris’s Biossance line of sustainable skincare products. “I have always been conscious of what’s being put on […]
In California, Amyris signed a memorandum of understanding for a partnership with Minerva Foods of Brazil to develop molecules for the sustainable production and distribution of animal protein. Minerva will fund Amyris’s development, scaling and production of new target molecules (with additional molecules to be identified over time), which Minerva will then be responsible for […]
In California, Amyris, Inc. has signed and closed an agreement with DSM Nutritional Products Ltd., a subsidiary of Royal DSM for the exclusive rights to supply Amyris’s product portfolio of flavor and fragrance (F&F) ingredients. Amyris will continue to develop, scale and manufacture future molecules with its existing partners and DSM. The total transaction value […]
In California, Amyris, Inc. achieved another breakthrough with its production of Cannabigerol (CBG) from fermentation for consumer skincare treatment formulations. Amyris believes that this production run is the largest industrial-scale fermentation-based CBG by any producer to-date. The production was completed utilizing 225,000 fermenters at the facility of Amyris’s Spain-based manufacturing partner. Amyris’s Lab-to-Market synthetic biology […]
Iowa –
